According to the American Cancer Society[3] , the cost of cancer treatment depends on the type and duration of treatment, and whether the patient is treated at home, in a clinic, in the doctor's office, or in the hospital. For lung cancer in particular, treatment[4] typically involves ...
Apixaban is a cost-effective alternative to warfarin and dabigatran and is dominant over rivaroxaban in AF patients from the perspective of the Portuguese national healthcare system. These conclusions are based on indirect comparisons, but despite this limitation, the information is ...
Background: In the double-blind phase III ADAURA randomized clinical trial, adjuvant osimertinib showed a substantial overall survival benefit in patients with stage IB to IIIA, EGFR-mutated, completely resected non-small cell lung cancer (NSCLC). We conduct a cost-effectiveness analysis comparing th...
Even though, new drugs have invigorated the global lung cancer therapeutics market, the expiry of patents on the current drugs may also negatively impact the market. As the cost of developing the drugs is increasing, it has forced the drug manufacturers to reduce their investments in research &...
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated wit
OPINION STATEMENT: NSCLC is the leading cause of cancer mortality in the United States. Approximately 30-40% of patients present with advanced stage diseas... MB Lustberg,MJ Edelman - 《Curr Treat Options Oncol》 被引量: 174发表: 2007年 Clinical and cost effectiveness of paclitaxel, docetaxel...
While no differences in overall patient survival were observed, it seems reasonable to expect improvements in this outcome in upcoming years as more patients receive innovative treatments. Keywords: lung cancer; real-world data; immunotherapy; targeted therapy; overall survival; cost of treatment...
Examples of VA benefits includemonthly disability payouts, free or reduced-cost medical treatment, and survivors pensionsfor spouses and children. Asbestos Lung Cancer vs. Mesothelioma Asbestos lung cancer is not the same asmesothelioma cancer. While both diseases are caused directly by asbestos exposure...
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it. Read the Original This page is a summary of:Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost ...
small Cell Lung Cancer in China Xin-Zu Chen, MD, PhD JAMA Oncology Key Points Question Is osimertinib, a third-generation tyrosine kinase inhibitor (TKI), a cost-effective first-line therapy for treatment-naive, epidermal growth factor receptor gene (EGFR)-mutated, non–small cell lung cancer...